Group B streptococcus neonatal sepsis

2 trials MedDRA PT
2 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
2 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 1
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 2 substances
Phase II/III: 2

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase II/III

2 trials
  • Minervax ApS Commercial
    DIPHTHERIA TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, TETANUS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS TOXOID ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS PERTACTIN ADSORBED ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE, PERTUSSIS FILAMENTOUS HAEMAGGLUTININ ON ALUMINIUM HYDROXIDE, HYDRATED AND ALUMINIUM PHOSPHATE; GBS-NN, GBS-NN2
    2023-508563-73-00 2 countries n=564
    Pending
  • Minervax ApS Commercial
    GBS-NN, GBS-NN2
    2024-516364-28-00 1 country 2025 n=52
    Ended
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Minervax ApS Commercial 2 Phase II/III 0
New trials by year
2025
1
← All indication landscapes